SCHEMBL10246717

SCHEMBL10246717

CC(C)CN(CCC(=O)O)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 2/20 0.44
PHF8 Q9UPP1 2/20 0.44
KDM2A Q9Y2K7 2/20 0.44
KDM4A O75164 1/20 0.44
GABRP O00591 2/20 0.37
GABRD O14764 2/20 0.37
GABRA1 P14867 2/20 0.37
GABRB1 P18505 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
GABRA2 P47869 2/20 0.37
GABRB2 P47870 2/20 0.37
GABRA4 P48169 2/20 0.37
GABRE P78334 2/20 0.37
GABRA6 Q16445 2/20 0.37
GABRG1 Q8N1C3 2/20 0.37
GABRG3 Q99928 2/20 0.37
GABRQ Q9UN88 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4247084 0.86 GABRP (0.42) KDM4CPHF8KDM2AKDM4AGABRP
SCHEMBL23693497 0.85 KDM4C (0.47) KDM4CPHF8KDM2AKDM4AGABRP
SCHEMBL26209746 0.80 TDP1 (0.39) KDM4CPHF8KDM2AKDM4AGABRP
SCHEMBL3195705 0.80 ALDH1A1 (0.42) KDM4CPHF8KDM2AKDM4AGABRP
SCHEMBL3187223 0.78 FFAR3 (0.44) KDM4CFFAR3HDAC3HDAC1HDAC2
SCHEMBL20198667 0.78 KDM4C (0.37) KDM4CPHF8KDM2AKDM4AGABRP
SCHEMBL11212413 0.78 GABRP (0.41) KDM4CPHF8KDM2AKDM4AGABRP
SCHEMBL12269098 0.78 CAMK2A (0.37) KDM4CPHF8KDM2AKDM4AGABRP
SCHEMBL9225685 0.77 KDM4C (0.47) KDM4CPHF8KDM2AKDM4AGABRP
SCHEMBL26724520 0.77 LMNA (0.41) KDM4CPHF8KDM2AKDM4AGABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815919-B2 Oxadiazole derivatives MERCK SERONO SA (CH) 2014-08-26 US disclosed
US-20120022109-A1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022109-A1 OXADIAZOLE DERIVATIVES OXA1L, HLA-DRB1, SSB KDM4C 2950/4885PHF8 3002/4885KDM2A 3042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.